Over the course of PCa development and progression, from treatment-naïve primary tumors to CRPC to metastatic CRPC (mCRPC), significant heterogeneity in AR and PSA expression have been demonstrated [2,5,6]. Here, AR is linked to posterior cortical atrophy.